Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 27, Issue 10, Pages 1712-1717
Publisher
Springer Science and Business Media LLC
Online
2021-10-05
DOI
10.1038/s41591-021-01479-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety, tolerability, and pharmacokinetics of single‐ and multiple‐dose administration of islatravir (MK‐8591) in adults without HIV
- (2021) Randolph P. Matthews et al. CTS-Clinical and Translational Science
- Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial
- (2020) Dirk Schürmann et al. Lancet HIV
- Drug eluting implants in pharmaceutical development and clinical practice
- (2020) Ashley R. Johnson et al. Expert Opinion on Drug Delivery
- Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis
- (2020) Manjula Gunawardana et al. Frontiers in Pharmacology
- Decreased tenofovir diphosphate concentrations in a transgender female cohort: Implications for HIV pre-exposure prophylaxis (PrEP)
- (2019) Mackenzie L Cottrell et al. CLINICAL INFECTIOUS DISEASES
- 2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis
- (2019) Fernanda P. Pons-Faudoa et al. JOURNAL OF CONTROLLED RELEASE
- Preexposure Prophylaxis for the Prevention of HIV Infection
- (2019) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Once-Weekly Oral Dosing of MK-8591 Protects Male Rhesus Macaques From Intrarectal Challenge With SHIV109CP3
- (2019) Martin Markowitz et al. JOURNAL OF INFECTIOUS DISEASES
- Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline
- (2019) Lara Esteves Coelho et al. Lancet HIV
- Islatravir for the treatment and prevention of infection with the human immunodeficiency virus type 1
- (2019) Martin Markowitz et al. Current Opinion in HIV and AIDS
- Extended Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention
- (2018) Stephanie E. Barrett et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- HIV Preexposure Prophylaxis
- (2018) James Riddell et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 4′-Ethynyl-2-fluoro-2′-deoxyadenosine, MK-8591
- (2018) Martin Markowitz et al. Current Opinion in HIV and AIDS
- Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial
- (2018) Sinead Delany-Moretlwe et al. LANCET INFECTIOUS DISEASES
- Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial
- (2017) Martin Markowitz et al. Lancet HIV
- Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
- (2016) Virginia A. Fonner et al. AIDS
- A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine
- (2016) Mackenzie L. Cottrell et al. JOURNAL OF INFECTIOUS DISEASES
- Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
- (2016) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis of HIV inhibition by translocation-defective RT inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA)
- (2016) Zhe Li Salie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oral Administration of the Nucleoside EFdA (4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine) Provides Rapid Suppression of HIV Viremia in Humanized Mice and Favorable Pharmacokinetic Properties in Mice and the Rhesus Macaque
- (2015) Cheryl A. Stoddart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring
- (2015) Monica Gandhi et al. JOURNAL OF INFECTIOUS DISEASES
- Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
- (2015) Jeanne M. Marrazzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- 4′-Ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) Inhibits HIV-1 Reverse Transcriptase with Multiple Mechanisms
- (2014) Eleftherios Michailidis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Strong Relationship between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP)
- (2014) Albert Y. Liu et al. PLoS One
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
- (2012) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preexposure Prophylaxis for HIV Infection among African Women
- (2012) Lut Van Damme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission
- (2011) K. B. Patterson et al. Science Translational Medicine
- HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy
- (2010) Steven J Reynolds et al. AIDS
- Efficacy of contraceptive methods: A review of the literature
- (2010) Diana Mansour et al. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
- (2010) Robert M. Grant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Implanon: A Review of the Literature With Recommendations for Clinical Management
- (2009) Kate Adams et al. JOURNAL OF MIDWIFERY & WOMENS HEALTH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started